168 related articles for article (PubMed ID: 33029806)
1. Pharmacokinetics of Hydrochlorothiazide in Children: A Potential Surrogate for Renal Secretion Maturation.
Commander SJ; Wu H; Boakye-Agyeman F; Melloni C; Hornik CD; Zimmerman K; Al-Uzri A; Mendley SR; Harper B; Cohen-Wolkowiez M; Hornik CP;
J Clin Pharmacol; 2021 Mar; 61(3):368-377. PubMed ID: 33029806
[TBL] [Abstract][Full Text] [Related]
2. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.
Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418
[TBL] [Abstract][Full Text] [Related]
3. Population-based meta-analysis of hydrochlorothiazide pharmacokinetics.
Van Wart SA; Shoaf SE; Mallikaarjun S; Mager DE
Biopharm Drug Dispos; 2013 Dec; 34(9):527-39. PubMed ID: 24123104
[TBL] [Abstract][Full Text] [Related]
4. Association of intergenic polymorphism of organic anion transporter 1 and 3 genes with hypertension and blood pressure response to hydrochlorothiazide.
Han YF; Fan XH; Wang XJ; Sun K; Xue H; Li WJ; Wang YB; Chen JZ; Zhen YS; Zhang WL; Zhou X; Hui R
Am J Hypertens; 2011 Mar; 24(3):340-6. PubMed ID: 21164499
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol.
Hsiao HL; Langenickel TH; Greeley M; Roberts J; Zhou W; Pal P; Rebello S; Rajman I; Sunkara G
Clin Pharmacol Drug Dev; 2015 Nov; 4(6):407-17. PubMed ID: 27137712
[TBL] [Abstract][Full Text] [Related]
6. Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3.
Cristea S; Krekels EHJ; Allegaert K; De Paepe P; de Jaeger A; De Cock P; Knibbe CAJ
AAPS J; 2021 May; 23(3):65. PubMed ID: 33948771
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profiles of hydrochlorothiazide alone and in combination with benazepril or valsartan in healthy Chinese volunteers: evaluation of the potential interaction.
Jiang J; Tian L; Huang Y; Xie S; Xu L; Liu H; Li Y
Int J Clin Pharmacol Ther; 2011 Dec; 49(12):756-64. PubMed ID: 22122818
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.
Pareek AK; Messerli FH; Chandurkar NB; Dharmadhikari SK; Godbole AV; Kshirsagar PP; Agarwal MA; Sharma KH; Mathur SL; Kumbla MM
J Am Coll Cardiol; 2016 Feb; 67(4):379-389. PubMed ID: 26821625
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydrochlorothiazide on the pharmacokinetics, pharmacodynamics, and tolerability of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.
Devineni D; Vaccaro N; Polidori D; Rusch S; Wajs E
Clin Ther; 2014 May; 36(5):698-710. PubMed ID: 24726680
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
Bhad P; Ayalasomayajula S; Karan R; Leon S; Riviere GJ; Sunkara G; Jarugula V
J Clin Pharmacol; 2011 Jun; 51(6):933-42. PubMed ID: 20852001
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic interaction between irbesartan and hydrochlorothiazide in renal hypertensive dogs.
Huang XH; Qiu FR; Xie HT; Li J
J Cardiovasc Pharmacol; 2005 Dec; 46(6):863-9. PubMed ID: 16306814
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial.
Blanchard A; Vargas-Poussou R; Peyrard S; Mogenet A; Baudouin V; Boudailliez B; Charbit M; Deschesnes G; Ezzhair N; Loirat C; Macher MA; Niaudet P; Azizi M
Am J Kidney Dis; 2008 Dec; 52(6):1084-95. PubMed ID: 18976849
[TBL] [Abstract][Full Text] [Related]
13. Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.
Hsueh CH; Yoshida K; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
Mol Pharm; 2016 Sep; 13(9):3130-40. PubMed ID: 27467266
[TBL] [Abstract][Full Text] [Related]
14. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
White WB; Davidai G; Schumacher H
J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698
[TBL] [Abstract][Full Text] [Related]
15. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.
Roush GC; Abdelfattah R; Song S; Ernst ME; Sica DA; Kostis JB
J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1507-1515. PubMed ID: 30251403
[TBL] [Abstract][Full Text] [Related]
16. Fosinopril and hydrochlorothiazide combination versus individual components: lack of a pharmacokinetic interaction.
Uderman HD; Much DR; Brennan J; Delaney CL; Morgenthien EA; Weaver J; Stouffer BC; Chang SY; VanHarken D; Liao W
Ann Pharmacother; 1999 May; 33(5):525-30. PubMed ID: 10369612
[TBL] [Abstract][Full Text] [Related]
17. The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study.
de Haan-Du J; Landman GWD; Groenier KH; Vissers PAJ; Louwman MWJ; Kleefstra N; de Bock GH
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2114-2121. PubMed ID: 34493493
[TBL] [Abstract][Full Text] [Related]
18. Assessing pharmacokinetic interactions between the sodium glucose cotransporter 2 inhibitor empagliflozin and hydrochlorothiazide or torasemide in patients with type 2 diabetes mellitus: a randomized, open-label, crossover study.
Heise T; Mattheus M; Woerle HJ; Broedl UC; Macha S
Clin Ther; 2015 Apr; 37(4):793-803. PubMed ID: 25636696
[TBL] [Abstract][Full Text] [Related]
19. Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics.
Vallon V; Rieg T; Ahn SY; Wu W; Eraly SA; Nigam SK
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F867-73. PubMed ID: 18216144
[TBL] [Abstract][Full Text] [Related]
20. Chlorothiazide is a substrate for the human uptake transporters OAT1 and OAT3.
Juhász V; Beéry E; Nagy Z; Bui A; Molnár E; Zolnerciks JK; Magnan R; Jani M; Krajcsi P
J Pharm Sci; 2013 May; 102(5):1683-7. PubMed ID: 23457060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
